Loke-Khoon Tan and James Lau of Baker McKenzie highlight the changes to the Guidelines for the Review and Examination of Trademarks, which promise to offer more protection to brand owners in terms of clarifying what a bad faith trademark application is and inclusion of non-traditional marks, as well as other changes to the examination standards
European Union takes China to World Trade Organization over patent anti-suit injunctions; China sanctions U.S. defense giants under anti-foreign sanctions law; and ride-hailing operators on notice to increase compliance
2021 regulatory trends in China, including antitrust, data privacy, sanctions, healthcare, PE/VC, capital markets, IP, banking & finance, TMT and arbitration.
China joins the WIPO treaty on protecting industrial designs; Hong Kong, mainland M&A hits record heights in 2021 despite regulatory headwinds; and e-CNY to be piloted in retail shops across Hong Kong
Regulation of platform economy to focus on anti-trust, data security, and personal information protection; U.S. might ban import of rare earth metals from China for military use; new process to expedite application of certain trademarks
Aggie Liu, Binxin Li, Yun Chen and Muzi Xuan of FenXun Partners, highlight China's 2021 legislative and enforcement developments in the intellectual property sector including how they respond to challenges posed by emerging technologies and stimulate innovative vitality, significant cases that strengthen IP protection mechanisms and standards, and what the future holds for IP in 2022
Groundbreaking algorithm recommendation regulation finalized; CSRC pilots market makers for STAR Market; and copyright administration prohibits digital music exclusive copyright arrangements
Ting Wu of Haiwen & Partners reviews the regulatory reforms taking place in China's life science and healthcare sector including legislation that has been released to encourage innovation and broaden market access to drugs, implementation of the patent linkage system, increasing antitrust enforcement pressure in the pharma sector, regulating medical devices, cosmetics and online hospitals.
